Marieke S Walma
Overview
Explore the profile of Marieke S Walma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brada L, Schouten T, Daamen L, Seelen L, Walma M, Van Dam R, et al.
Ann Surg
. 2024 Apr;
PMID: 38557955
Objective: This study aims to evaluate short- and long-term outcomes following pancreatectomy in patients with LAPC compared to (B)RPC patients. Summary Background Data: Selected patients diagnosed with locally advanced pancreatic...
2.
Seelen L, Doppenberg D, Stoop T, Nagelhout A, Brada L, Bosscha K, et al.
Ann Surg
. 2023 Jul;
279(5):832-841.
PMID: 37477009
Objective: This nationwide multicenter study aimed to define clinically relevant thresholds of relative serum CA19-9 response after 2 months of induction chemotherapy in patients with locally advanced pancreatic cancer (LAPC)....
3.
Seelen L, Floortje van Oosten A, Brada L, Groot V, Daamen L, Walma M, et al.
Ann Surg
. 2022 Aug;
278(1):118-126.
PMID: 35950757
Objective: To establish an evidence-based cutoff and predictors for early recurrence in patients with resected locally advanced pancreatic cancer (LAPC). Background: It is unclear how many and which patients develop...
4.
Henry A, Schouten T, Daamen L, Walma M, Noordzij P, Cirkel G, et al.
Ann Surg Oncol
. 2022 Jun;
29(9):6031-6042.
PMID: 35653069
Background: The number of elderly patients with pancreatic cancer is growing, however clinical data on the short-term outcomes, rate of adjuvant chemotherapy, and survival in these patients are limited and...
5.
Brada L, Daamen L, Magermans L, Walma M, Latifi D, M van Dam R, et al.
Ann Surg
. 2021 Aug;
274(5):729-735.
PMID: 34334641
Objective: This study compared median OS after resection of LAPC after upfront FOLFIRINOX versus a propensity-score matched cohort of LAPC patients treated with FOLFIRINOX-only (ie, without resection). Background: Because the...
6.
Brada L, Walma M, Daamen L, van Roessel S, M van Dam R, de Hingh I, et al.
J Surg Oncol
. 2021 Jun;
124(4):589-597.
PMID: 34115379
Background And Objectives: Patients with locally advanced pancreatic cancer (LAPC) are increasingly treated with FOLFIRINOX, resulting in improved survival and resection of tumors that were initially unresectable. It remains unclear,...
7.
Walma M, Brada L, Patuleia S, Blomjous J, Bollen T, Bosscha K, et al.
Eur J Surg Oncol
. 2020 Dec;
47(3 Pt B):699-707.
PMID: 33280952
Introduction: Since current studies on locally advanced pancreatic cancer (LAPC) mainly report from single, high-volume centers, it is unclear if outcomes can be translated to daily clinical practice. This study...
8.
van Veldhuisen E, van den Oord C, Brada L, Walma M, Vogel J, Wilmink J, et al.
Cancers (Basel)
. 2019 Jul;
11(7).
PMID: 31336859
Locally advanced pancreatic cancer (LAPC) has several definitions but essentially is a nonmetastasized pancreatic cancer, in which upfront resection is considered not beneficial due to extensive vascular involvement and consequent...
9.
Fegrachi S, Walma M, De Vries J, van Santvoort H, Besselink M, von Asmuth E, et al.
Eur J Surg Oncol
. 2019 Jun;
45(11):2166-2172.
PMID: 31227340
Introduction: Radiofrequency ablation (RFA) has been proposed as a new treatment option for locally advanced, unresectable pancreatic cancer (LAPC). In preparation of a randomized controlled trial (RCT), the aim of...
10.
van Veldhuisen E, Walma M, van Rijssen L, Busch O, Bruijnen R, van Delden O, et al.
HPB (Oxford)
. 2019 Apr;
21(10):1385-1392.
PMID: 31010633
Background: Determining the resectability of locally advanced pancreatic cancer (LAPC) after FOLFIRINOX chemotherapy is challenging because CT-scans cannot reliably assess vascular involvement. This study evaluates the added value of intra-operative...